These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32451342)

  • 61. Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials.
    Herring WJ; Connor KM; Ivgy-May N; Snyder E; Liu K; Snavely DB; Krystal AD; Walsh JK; Benca RM; Rosenberg R; Sangal RB; Budd K; Hutzelmann J; Leibensperger H; Froman S; Lines C; Roth T; Michelson D
    Biol Psychiatry; 2016 Jan; 79(2):136-48. PubMed ID: 25526970
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Suvorexant for the treatment of insomnia.
    Jacobson LH; Callander GE; Hoyer D
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):711-30. PubMed ID: 25318834
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Edoxaban tosylate monohydrate, secukinumab, and suvorexant.
    Hussar DA; Jacob J
    J Am Pharm Assoc (2003); 2015; 55(5):563-7. PubMed ID: 26359966
    [No Abstract]   [Full Text] [Related]  

  • 64. Astemizole in the treatment of seasonal allergic rhinitis. A double- blind comparison with clemastine in patients sensitive to tree and grass pollen. Special reference to side effects registered in psychological tests.
    Frostad AB; L ofkvist T; Norell I; Svensson G; Wahlberg P; Ellertsen B
    Acta Otolaryngol Suppl; 1984; 409():1-30. PubMed ID: 6437136
    [No Abstract]   [Full Text] [Related]  

  • 65. Profile of suvorexant in the management of insomnia.
    Sutton EL
    Drug Des Devel Ther; 2015; 9():6035-42. PubMed ID: 26648692
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Nefazodone in major depression: adjunctive benzodiazepine therapy and tolerability.
    Rickels K; Schweizer E; Case WG; DeMartinis N; Greenblatt DJ; Mandos LA; Garcia España FG
    J Clin Psychopharmacol; 1998 Apr; 18(2):145-53. PubMed ID: 9580369
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Treatment for insomnia.
    Finucane TE
    Lancet; 2002 Apr; 359(9315):1434; author reply 1434. PubMed ID: 11978363
    [No Abstract]   [Full Text] [Related]  

  • 68. [Sleeplessness. Helping with paradoxical medication].
    Epple O
    MMW Fortschr Med; 2005 Dec; 147(49-50):22. PubMed ID: 16401006
    [No Abstract]   [Full Text] [Related]  

  • 69. [Effect of buflomedil on the behavior of platelet aggregation and its clinical evaluation in elderly patients with chronic cerebrovascular insufficiency].
    Cajozzo A; Abbadessa V; Musso M; Iannitto E
    Minerva Med; 1983 Jul; 74(28-29):1727-31. PubMed ID: 6346139
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Pharmacological treatment of insomnia].
    Wichniak A; Murawiec S; Jernajczyk W
    Psychiatr Pol; 2006; 40(3):563-77. PubMed ID: 17037820
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Understanding and treating insomnia.
    Bootzin RR; Epstein DR
    Annu Rev Clin Psychol; 2011; 7():435-58. PubMed ID: 17716026
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Review of Safety and Efficacy of Sleep Medicines in Older Adults.
    Schroeck JL; Ford J; Conway EL; Kurtzhalts KE; Gee ME; Vollmer KA; Mergenhagen KA
    Clin Ther; 2016 Nov; 38(11):2340-2372. PubMed ID: 27751669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Insomnia in geriatrics.
    Setiati S; Laksmi PW
    Acta Med Indones; 2005; 37(4):224-9. PubMed ID: 16317220
    [No Abstract]   [Full Text] [Related]  

  • 74. Evaluating and managing insomnia.
    Fisher D; Valente S
    Nurse Pract; 2009 Aug; 34(8):20-6; quiz 27. PubMed ID: 19638890
    [No Abstract]   [Full Text] [Related]  

  • 75. Management of insomnia.
    Kupfer DJ; Reynolds CF
    N Engl J Med; 1997 Jan; 336(5):341-6. PubMed ID: 9011788
    [No Abstract]   [Full Text] [Related]  

  • 76. Patient Education and Pharmacist Consultation Influence on Nonbenzodiazepine Sedative Medication Deprescribing Success for Older Adults.
    Kuntz JL; Kouch L; Christian D; Hu W; Peterson PL
    Perm J; 2019; 23():18-161. PubMed ID: 30624198
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Suvorexant: scientifically interesting, utility uncertain.
    Keks NA; Hope J; Keogh S
    Australas Psychiatry; 2017 Dec; 25(6):622-624. PubMed ID: 28994603
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection.
    Suda G; Hasebe C; Abe M; Kurosaki M; Itakura J; Izumi N; Uchida Y; Mochida S; Haga H; Ueno Y; Abe K; Takahashi A; Ohira H; Tsukuda Y; Furuya K; Baba M; Yamamoto Y; Kobayashi T; Inoue J; Terasita K; Ohara M; Kawagishi N; Izumi T; Nakai M; Sho T; Natsuizaka M; Morikawa K; Ogawa K; Sakamoto N;
    J Gastroenterol; 2019 Jul; 54(7):641-649. PubMed ID: 30778716
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Insomnia in the elderly.
    Monane M
    J Clin Psychiatry; 1992 Jun; 53 Suppl():23-8. PubMed ID: 1613016
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Cost-effectiveness analysis of suvorexant for the treatment of Japanese elderly patients with chronic insomnia in a virtual cohort.
    Nishimura S; Nakao M
    J Med Econ; 2018 Jul; 21(7):698-703. PubMed ID: 29667471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.